Midazolam
Also known as: Nayzilam.
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Package | Class |
|---|---|---|---|---|
| 2 MG/2 ML | Vial | $0.231 / mL† | — | Generic |
| 2 MG/ML | Syrup | $0.687 / mL | — | Generic |
| 5 MG/ML | Vial | $1.15 / mL† | — | Generic |
| 5 MG | Spray | $327.11 / unit | — | Brand |
| 10 MG/2 ML | Vial | $0.565 / mL† | — | Generic |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price. Brand list prices fall after confidential rebates. † Package size not curated yet — priced per single unit/mL, not per full pen, inhaler, or vial. Liquids, creams, and sprays are priced per mL or gram; a typical package may be a bottle or tube (size not set yet).
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $106,802,754 gross for Midazolam across 267,526 prescriptions (measured, national).
Medicare Part D EST spent an estimated ~$161,069 gross (retail pharmacy only; excludes Part B).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS